LY3971297

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3971297, covering 2026-04-20 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3971297 in Participants With Heart Failure [Phase 1]